Key Takeaways: GLP-1 vs GIP Both are incretin hormones released by your intestines after eating GLP-1 primarily affects appetite, gastric emptying, and insulin secretion GIP influences insulin secretion, glucagon regulation, and fat metabolism Single GLP-1 agonists (semaglutide) produce 14.9% average weight loss Dual GLP-1/GIP agonists (tirzepatide) produce 22.5% average weight loss The dual action appears to create additive rather than merely overlapping effects Both receptor types play important roles in metabolic regulation Understanding the difference helps explain why tirzepatide shows superior results What Are Incretin Hormones
and Mounjaro (tirzepatide) was approved in May 2022
The fact is, our biology is programmed for a very different environment than our current surroundings
Use the arrows to see more real patient stories 4,500+ patients and counting have changed their lives with MDWatch Check your Medicare benefits See if you qualify in minutes free, with no obligation
For example, Tianjin Shiji Living Engineering Co., Ltd
Inconsistent angles produce inconsistent results
